StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Triethylamine → 4-[(4-{3-cyano-2-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propyl}piperazin-1-yl)carbonyl]-3,5-difluorobenzonitrile

HRID 1772796
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1772796
[C:1]([C:3]1[CH:11]=[C:10]([F:12])[C:6]([C:7]([OH:9])=O)=[C:5]([F:13])[CH:4]=1)#[N:2].F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1.C(N(CC)CC)C.Cl.[N:49]1([CH2:55][CH:56]([N:60]2[CH:64]=[C:63]([C:65]3[C:66]4[CH:73]=[CH:72][N:71](COCC[Si](C)(C)C)[C:67]=4[N:68]=[CH:69][N:70]=3)[CH:62]=[N:61]2)[CH2:57][C:58]#[N:59])[CH2:54][CH2:53][NH:52][CH2:51][CH2:50]1>CN(C=O)C.C(OCC)(=O)C>[C:58]([CH2:57][CH:56]([N:60]1[CH:64]=[C:63]([C:65]2[C:66]3[CH:73]=[CH:72][NH:71][C:67]=3[N:68]=[CH:69][N:70]=2)[CH:62]=[N:61]1)[CH2:55][N:49]1[CH2:50][CH2:51][N:52]([C:7]([C:6]2[C:5]([F:13])=[CH:4][C:3]([C:1]#[N:2])=[CH:11][C:10]=2[F:12])=[O:9])[CH2:53][CH2:54]1)#[N:59]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 8471Triethylamine2×HCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate2×HCID 445579334-Cyano-2,6-difluorobenzoic acid2×HCID 670549114-piperazin-1-yl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]butanenitrile hydrochloride

Produkt 1

HCID 50995999
4-[(4-{3-cyano-2-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propyl}piperazin-1-yl)carbonyl]-3,5-difluorobenzonitrile

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittel2×HCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

4-Cyano-2,6-difluorobenzoic acid (82 mg, 0.32 mmol), Benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (110 mg, 0.00025 mol) and triethylamine (180 uL, 0.0013 mol) were stirred together in DMF (0.5 mL) for 15 minutes. 4-Piperazin-1-yl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]butanenitrile hydrochloride (125 mg, 0.211 mmol; from Example 12, Step 2) was added and the reaction stirred for 16 hours. To push the reaction to completion, additional 4-cyano-2,6-difluorobenzoic acid (82 mg, 0.32 mol) and triethylamine (58.9 uL, 0.000422 mol) were mixed, in a separate vial, in N,N-Dimethylformamide (1.6 mL) and benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (110 mg, 0.25 mmol) was added. This mixture was stirred separately for 15 minutes, and then was added to the incomplete original reaction mixture. The reaction was continued for 1.5 hours, then was diluted with a large quantity of ethyl acetate. The solution was washed with three portions of water, once with brine, dried over sodium sulfate and concentrated. The residue was stirred in a mixture of 1:1 dichloromethane (DCM):TFA for one hour, was concentrated, then was stirred in methanol (3 mL) containing ethylenediamine (0.5 mL) until deprotection was complete as evidenced by LCMS. Two successive purifications vial HPLC-MS (eluting first with a gradient of MeCN/H2O containing 0.1% TFA, then repurification eluting with a gradient of MeCN/H2O containing 0.15% NH4OH afforded clean product (46 mg, 43%). 1H NMR (400 MHz, d6-dmso): δ 12.11 (br s, 1H), 8.81 (s, 1H), 8.67 (s, 1H), 8.37 (s, 1H), 7.98-7.91 (m, 2H), 7.60 (d, 1H), 6.97 (d, 1H), 5.02-4.93 (tt, 1H), 3.66-3.54 (m, 2H), 3.25-3.16 (m, 4H), 2.91-2.78 (m, 2H), 2.63-2.54 (m, 1H), 2.52-2.38 (m, 2H), 2.37-2.28 (m, 1H); LCMS (M+H)+: 502.1.

Aufarbeitung

  1. additionwere mixed
  2. stirringThis mixture was stirred separately for 15 minutes
  3. additionwas added to the incomplete original reaction mixture
  4. waitThe reaction was continued for 1.5 hours
  5. washThe solution was washed with three portions of water, once with brine
  6. dry with materialdried over sodium sulfate
  7. concentrationconcentrated
  8. stirringThe residue was stirred in a mixture of 1:1 dichloromethane (DCM)
  9. waitTFA for one hour
  10. concentrationwas concentrated
  11. stirringwas stirred in methanol (3 mL)
  12. additioncontaining ethylenediamine (0.5 mL) until deprotection
  13. washTwo successive purifications vial HPLC-MS (eluting first with a gradient of MeCN/H2O containing 0.1% TFA
  14. customrepurification
  15. washeluting with a gradient of MeCN/H2O containing 0.15% NH4OH afforded clean product (46 mg, 43%)

Quellen und Nachweise

ORD-Eintrag
ord-70dcd285c31b408481310f222ea7ad7c
Quelldatensatz
uspto-grants-2016_02
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09249145B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion